文章摘要

IA期乳腺癌临床病理特征及预后相关因素分析

作者: 1陆宁, 1刘晓东, 1谢晓娟, 1汪旭
1 天津医科大学肿瘤医院 乳腺肿瘤科/国家肿瘤临床医学研究中心/天津市“肿瘤防治”重点实验室/天津市恶性肿瘤临床医学研究中心/乳腺癌防治教育部重点实验室,天津 300060
通讯: 陆宁 Email: luning@medmail.com.cn
DOI: 10.3978/.10.3978/j.issn.1005-6947.2016.08.018
基金: 国家科技支撑计划资助项目, 2005BAI12B15

摘要

目的:探讨IA期乳腺癌患者的临床病理特征与预后因素。方法:回顾性分析2004年1月—2009年12月天津医科大学肿瘤医院收治的156例IA期(T1N0M0,)乳腺癌患者的临床病理资料。结果:156例患者均为女性;病理类型以浸润性导管癌为主(115例,73.7%);原发肿瘤大小以T1c居多(77例,49.4%);组织学分级以II级(79例,50.6%)及III级(58例,37.2%)为主。5年无进展生存(PFS)为93.3%,5年总生存(OS)为99.1%。单因素分析结果显示,组织学分级、Ki-67表达及淋巴脉管侵犯与患者的PFS有关(均P<0.05);多因素分析显示,组织学分级及Ki-67表达情况是影响患者PFS的独立预后因素(均P<0.05)。结论:IA期乳腺癌患者虽然总体预后较好,但对于某些亚组患者而言,预后较差,该类患者的复发转移风险较大。
关键词: 乳腺肿瘤 无病生存 危险因素

Clinicopathologic characteristics and prognostic factors of stage IA breast cancer

Authors: 1LU Ning, 1LIU Xiaodong, 1XIE Xiaojuan, 1WANG Xu
1 Department of Breast Oncology/National Clinical Research Center for Cancer/Tianjin Key Laboratory of Breast Cancer Prevention and Therapy/Tianjin Clinical Research Center for Malignant Tumors/Key Laboratory of Breast Cancer Prevention and Treatment, Cancer Hospital, Tianjin Medical University, Tianjin 300060, China

CorrespondingAuthor:LU Ning Email: luning@medmail.com.cn

Abstract

Objective: To investigate the clinicopathologic characteristics and prognostic factors of patients with stage IA breast cancer. Methods: The clinicopathologic data of 156 patients with IA stage (T1N0M0) breast cancer treated in Cancer Hospital of Tianjin Medical University from January 2004 to December 2009 were retrospectively analyzed. Results: Of the 156 patients, all cases were female; infiltrate ductal carcinoma accounted for the majority of the pathological types (115 cases, 73.7%), the primary tumor sizes were mostly classified as T1c (77 cases, 49.4%) and histological grades were mainly grade II (79 cases, 50.6%) and III (58 cases, 37.2%). The 5-year progress-free survival (PFS) was 93.3% and overall survival (OS) was 99.1%, respectively. Univariate analysis showed that histological grade, Ki-67 expression and lymphvascular invasion were significantly related to the PFS of the patients (all P<0.05). Multivariate analysis identified that histological grade and Ki-67 expression were independent prognostic factors for PFS of the patients (both P<0.05). Conclusion: Although the overall prognosis of stage IA breast cancer patients is favorable, patients in some subgroups still have great risk of recurrence and metastases, and they have a poor prognosis.
Keywords: